Related Experiment Video
Updated: Dec 21, 2025

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro
Published on: March 7, 2022
Metabolite releasing polymers control dendritic cell function by modulating their energy metabolism
Joslyn L Mangal1, Sahil Inamdar2, Yi Yang2
1Biological Design Graduate Program, School for Biological and Health Systems Engineering, Arizona State University, Tempe, AZ 85281, USA. abhi.acharya@asu.edu.
Sustained release of alpha-ketoglutarate (aKG) via microparticles suppressed immune cell metabolism and function. This immunometabolism strategy shows potential for treating immune disorders.
Area of Science:
- Immunometabolism
- Immunotherapy
- Cellular Metabolism
Background:
- Metabolites are crucial regulators of immune cell functions.
- Sustained delivery of metabolites can modulate immune cell activity.
- Alpha-ketoglutarate (aKG) plays a role in cellular metabolic pathways.
Purpose of the Study:
- To synthesize polymeric-microparticles for sustained release of alpha-ketoglutarate (aKG).
- To investigate the effects of aKG-loaded microparticles (paKG MPs) on dendritic cell (DC) metabolism and immune phenotype.
- To explore the potential of this immunometabolism strategy for immunotherapy.
Main Methods:
- Synthesis of diol-based polymeric-microparticles loaded with alpha-ketoglutarate (aKG).
- In vitro incubation of dendritic cells (DCs) with paKG MPs.
- Analysis of intracellular metabolic profiles, including glycolysis and mitochondrial respiration.
- Flow cytometry assessment of DC surface markers (MHC-II, CD86) and T cell populations (Tregs, Th1/2/17).
Main Results:
- paKG MPs successfully delivered aKG and modulated intracellular metabolic pathways in DCs.
- aKG delivery led to decreased glycolysis and mitochondrial respiration in DCs.
- Metabolic changes in DCs resulted in altered expression of MHC-II and CD86.
- In vitro studies showed modulation of regulatory T cells (Tregs) and T-helper type-1/2/17 cell frequencies.
Conclusions:
- Sustained intracellular delivery of aKG using paKG MPs can suppress immune cell metabolism and function.
- This approach offers a novel strategy for immunometabolism-based immunotherapy.
- The findings suggest potential applications in treating diseases associated with immune dysregulation.
More Related Videos
06:09Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
Published on: June 22, 2016
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
Related Concept Videos
Regulation of Metabolism
Drugs that Stabilize Microtubules